TY - JOUR
T1 - Behandling af den ældre patient med hæmatologisk kræft
AU - Andersen, Nina
AU - Al-Mashadi, Ahmed Ludvigsen
AU - Curovic Rotbain, Emelie Hamotal
AU - Kristensen, Ida Bruun
AU - Lauritsen, Tine Bichel
AU - Poulsen, Christian Bjørn
AU - Ommen, Hans Beier
AU - Andersen, Christen Bertel Lykkegaard
AU - El-Galaly, Tarec Christoffer
AU - Abildgaard, Niels
PY - 2024/1/22
Y1 - 2024/1/22
N2 - During the last two decades, novel targeted therapies, in particular, »small molecules« for oral administration and monoclonal antibodies, have revolutionized the treatment and prognosis of haematological cancers. Generally, these treatments are well tolerated and therefore suitable for elderly patients. This review presents a short update on the current standard-of-care treatment of elderly patients with haematological cancer.
AB - During the last two decades, novel targeted therapies, in particular, »small molecules« for oral administration and monoclonal antibodies, have revolutionized the treatment and prognosis of haematological cancers. Generally, these treatments are well tolerated and therefore suitable for elderly patients. This review presents a short update on the current standard-of-care treatment of elderly patients with haematological cancer.
KW - Aged
KW - Antibodies, Monoclonal/therapeutic use
KW - Antineoplastic Agents/therapeutic use
KW - Hematologic Neoplasms
KW - Humans
U2 - 10.61409/V08230538
DO - 10.61409/V08230538
M3 - Tidsskriftartikel
C2 - 38305321
SN - 0041-5782
VL - 186
JO - Ugeskrift for Læger
JF - Ugeskrift for Læger
IS - 2
M1 - V08230538
ER -